NASDAQ:ANGO
AngioDynamics Stock News
$5.87
-0.160 (-2.65%)
At Close: Apr 24, 2024
Why AngioDynamics Stock Popped on Monday
01:21pm, Monday, 25'th Sep 2023
An investment bank initiated coverage of the stock with a buy rating this morning. The banker believes AngioDynamics stock could nearly triple over the next year.
AngioDynamics: Enormous Effort Required In Fiscal '24 To Reverse The Equity Picture
03:52am, Sunday, 17'th Sep 2023
AngioDynamics, Inc. posted mixed results in its FY'23 reports, with strong growth in its Med Tech division. The company's focus going forward will be on its Med Tech segment, which has shown high grow
AngioDynamics (ANGO) Flat As Market Sinks: What You Should Know
07:17pm, Thursday, 17'th Aug 2023
AngioDynamics (ANGO) closed at $8.58 in the latest trading session, marking no change from the prior day.
AngioDynamics' (ANGO) New FDA Recognition to Boost Treatment
12:29pm, Wednesday, 16'th Aug 2023
The FDA's grant of the Breakthrough Device designation for AngioDynamics' (ANGO) AngioVac is likely to remove thrombus and embolic material and minimize blood loss via blood recirculation.
Should Growth Investors Buy This Revolutionary Small-Cap Stock?
09:53am, Tuesday, 25'th Jul 2023
AngioDynamics' net sales and earnings rose in its fiscal fourth quarter. The company's future product launches could generate growth.
AngioDynamics (ANGO) Lags Q4 Earnings Estimates
09:34am, Wednesday, 12'th Jul 2023
AngioDynamics (ANGO) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.01 per share a year ago.
AngioDynamics (ANGO) Reports Next Week: Wall Street Expects Earnings Growth
11:32am, Wednesday, 05'th Jul 2023
AngioDynamics (ANGO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
04:01pm, Tuesday, 20'th Jun 2023
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expand
Why Shares of AngioDynamics Rose Friday
02:56pm, Friday, 09'th Jun 2023
AngioDynamics makes vascular and oncology-related medical devices. AngioDynamics netted $100 million in its assets sale.
New Strong Sell Stocks for May 18th
09:12am, Thursday, 18'th May 2023
ANGO, FPAY and BRDG have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2023.
Is the Options Market Predicting a Spike in AngioDynamics (ANGO) Stock?
11:26am, Monday, 15'th May 2023
Investors need to pay close attention to AngioDynamics (ANGO) stock based on the movements in the options market lately.
Sell These 4 Toxic Stocks to Prevent Portfolio Losses
10:41am, Monday, 15'th May 2023
The basic understanding of toxic stocks can help investors avoid huge losses and derive maximum benefit from their portfolios. Some toxic stocks that investors may consider dumping are BROS, CHGG, PI
Top 5 Health Care Stocks That Are Preparing To Pump In Q2 - AngioDynamics (NASDAQ:ANGO), Apollomics (NASDAQ:APLM)
07:45am, Wednesday, 26'th Apr 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
4 Toxic Stocks That Are Detrimental to Your Portfolio's Health
10:39am, Friday, 14'th Apr 2023
Accurately identifying toxic stocks and getting rid of them at the right time can protect your portfolio. You should sell ANGO, DH, CWST and EVA.
Wall Street Thinks This Small-Cap Stock Can Double in Value
09:53am, Tuesday, 04'th Apr 2023
AngioDynamics' sales rose in its latest quarter. The medical device maker's financial health is solid.
